What is OS Therapies Incorporated's Market Cap?

OS Therapies Incorporated's Market Cap is $67.7M, based on as-reported figures from SEC (XBRL) filings.

What is OS Therapies Incorporated's Net Income (TTM)?

OS Therapies Incorporated's Net Income (TTM) is -$39.4M, based on as-reported figures from SEC (XBRL) filings.

What is OS Therapies Incorporated's EBITDA?

OS Therapies Incorporated's EBITDA is -$37.1M, based on as-reported figures from SEC (XBRL) filings.

What is OS Therapies Incorporated's Diluted EPS (TTM)?

OS Therapies Incorporated's Diluted EPS (TTM) is -1.06, based on as-reported figures from SEC (XBRL) filings.

OS Therapies Incorporated (OSTX) Financial Statements

OS Therapies Incorporated

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00Y71N7H6

XASE · usd

1.82▼ 0.01 (-0.32%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt—

Trading Information

Previous Close1.83

Day's Range1.75 – 2.02

52-Week Range1.15 – 2.35

Volume1.7M

Avg Volume430.7K

Share Statistics

Shares Outstanding

Employees5

ExchangeXASE

Listed2024-08-01

Share count as of December 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about OS Therapies Incorporated (OSTX)

What is OS Therapies Incorporated's Market Cap?: OS Therapies Incorporated's Market Cap is $67.7M, based on as-reported figures from SEC (XBRL) filings.
What is OS Therapies Incorporated's Net Income (TTM)?: OS Therapies Incorporated's Net Income (TTM) is -$39.4M, based on as-reported figures from SEC (XBRL) filings.
What is OS Therapies Incorporated's EBITDA?: OS Therapies Incorporated's EBITDA is -$37.1M, based on as-reported figures from SEC (XBRL) filings.
What is OS Therapies Incorporated's Diluted EPS (TTM)?: OS Therapies Incorporated's Diluted EPS (TTM) is -1.06, based on as-reported figures from SEC (XBRL) filings.